Sex differences in methamphetamine-evoked striatal dopamine of mice are reversed by nomifensine

Neurotoxicology and Teratology

Volumn 28, Issue 5, 2006, Pages 557-562

  Kunnathur, Vidhya ^a   Shemisa, Kamal ^a   Liu, Bin ^a   Salvaterra, Ty J ^a   Dluzen, Dean E ^a  

^a Northeastern Ohio Medical University   (United States)

Author keywords

Dopamine transporter; Gender differences; Neurodegeneration; Neurotoxicity; Nigrostriatal dopaminergic; Parkinson's disease

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE; NOMIFENSINE; POTASSIUM ION;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; EVOKED RESPONSE; FEMALE; MALE; MOUSE; NEUROBIOLOGY; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; FEMALE; MALE; METHAMPHETAMINE; MICE; NOMIFENSINE; POTASSIUM; SEX CHARACTERISTICS;

EID: 33750705659     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2006.07.001     Document Type: Article

References (35)

1. Baldereschi M., Di Carlo A., Rocca W.A., Vanni P., Maggi S., Perissinotto E., Grigoletto F., Amaducci L., Inzitari D., and ILSA Working Group. Italian Longitudinal Study on Aging, Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. Neurology 55 (2000) 1358-1363
2. Bhatt S.D., and Dluzen D.E. Dopamine transporter function differences between male and female CD-1 mice. Brain Res. 1035 (2005) 188-195
3. Bower J.H., Maraganore D.M., McDonnell S.K., and Rocca W.A. Influence of strict, intermediate and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease. Mov. Disord. 15 (2000) 819-825
4. Brecht M.-L., O'Brien A., von Mayrhauser C., and Anglin M.D. Methamphetamine use behaviors and gender differences. Addict. Behav. 29 (2004) 89-106
5. Brooks W.J., Jarvis M.F., and Wagner G.C. Influence of sex, age and strain of MPTP-induced neurotoxicity. Res. Commun. Subst. Abuse 10 (1989) 181-184
6. Cubells J.F., Rayport S., Rajendran G., and Sulzer D. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14 (1994) 2260-2271
7. Davidson C., Gow A.J., Lee T.H., and Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Rev. 36 (2001) 1-22
8. Dluzen D.E. The effect of gender and the neurotrophin, BDNF, upon methamphetamine-induced neurotoxicity of the nigrostriatal dopaminergic system in mice. Neurosci. Lett. 359 (2004) 135-138
9. Disshon K.A., and Dluzen D.E. Use of in vitro superfusion to assess the dynamics of striatal dopamine clearance: influence of estrogen. Brain Res. 842 (1999) 399-407
10. Dluzen D.E., and Salvaterra T.J. Sex differences in methamphetamine-evoked striatal dopamine output are abolished following gonadectomy: comparisons with potassium-evoked output and responses in pre-pubertal mice. Neuroendocrinology 82 (2005) 78-86
11. Dluzen D.E., Disshon K.A., and McDermott J.L. Estrogen as a modulator of striatal dopaminergic neurotoxicity. In: Marwah J., and Tietelbaum H. (Eds). Recent Advances in Neurodegenerative Disorders vol. 1 (1998), Prominent Press, Socttsdale, AZ 149-192
12. Dluzen D.E., Anderson L.I., and Pilati C.F. Methamphetamine-gonadal steroid interactions: effects upon acute toxicity and striatal dopamine concentrations. Neurotox. Teratol. 24 (2002) 267-273
13. Dluzen D.E., Tweed C., Anderson L.I., and Laping N.J. Gender differences in methamphetamine-induced mRNA associated with neurodegeneration in the nigrostriatal dopaminergic system. Neuroendocrinology 77 (2003) 232-238
14. Freyaldenhoven T.E., Cadet J.L., and Ali S.F. The dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender dependent. Brain Res. 735 (1996) 232-238
15. Fumagalli F., Gainetdinov R.R., Valenzano K.J., and Caron M.G. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. Neuroscience 18 (1998) 4861-4869
16. Hall J.N., and Broderick P.M. Community networks for response to abuse outbreaks of methamphetamine and its analogs. NIDA Res. Monog. 115 (1991) 109-120
17. Heller A., Bubla N., Lew R., Heller B., and Won L. Gender dependent enhanced adult neurotoxic response to methamphetamine following fetal exposure to the drug. J. Pharmacol. Exp. Ther. 298 (2001) 769-779
18. Kahlig K.M., Binda F., Koshbouei H., Blakely R.D., McMahon D.G., Javitch J.A., and Galli A. Amphetamine induces dopamine efflux through a dopamine transporter channel. PNAS 102 (2005) 3495-3500
19. Lavalaye J., Booij J., Reneman L., Habraken J.B., and van Royen E.A. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur. J. Nucl. Med. 27 (2000) 867-869
20. Metzger R.R., Brown J.M., Sandoval V., Rau K.S., Elwan M.A., Miller G.W., Hanson G.R., and Fleckenstein A.E. Inhibitory effects of reserpine on dopamine transporter function. Eur. J. Pharmacol. 456 (2001) 39-43
21. Miller D.B., Ali S.F., O'Callaghan J.P., and Laws S.C. The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann. N.Y. Acad. Sci. 844 (1998) 153-156
22. Morissette M., and Di Paolo T. Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites. J. Neurochem. 60 (1993) 1867-1883
23. Morissette M., and Di Paolo T. Sex and estrous cycle variations of rat striatal dopamine uptake sites. Neuroendocrinology 58 (1993) 16-22
24. Morissette M., Biron D., and Di Paolo T. Effect of estradiol and progesterone on striatal dopamine uptake sites. Brain Res. Bull. 25 (1990) 419-422
25. Morissette M., Garcia-Segura L.-M., Belanger A., and Di Paolo T. Changes of rat striatal neuronal membrane morphology and steroid content during the estrous cycle. Neuroscience 49 (1992) 893-902
26. Myers R.E., Anderson L.I., and Dluzen D.E. Estrogen, but not testosterone, attenuates methamphetamine-evoked dopamine output from superfused striatal tissue of female and male mice. Neuropharmacology 44 (2003) 624-632
27. Rivest R., Falardeau P., and Di Paolo T. Brain dopamine transporter: gender differences and effect of chronic haloperidol. Brain Res. 692 (1995) 269-272
28. Schrag A., Jahanshahi M., and Quinn N.P. What contributes to depression in Parkinson's disease?. Psychol. Med. 31 (2001) 65-73
29. Stanford J.A., Currier T.D., Purdom M.S., and Gerhardt G.A. Nomifensine reveals age-related changes in K+-evoked striatal DA overflow in F344 rats. Neurobiol. Aging 22 (2001) 495-502
30. Swerdlow R.H., Parks J.K., Cassarino D.S., Binder D.R., Bennet Jr. J.P., Di Iori G., Golbe L.I., and Parker Jr. W.D. Biochemical analysis of hybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects. Exp. Neurol. 169 (2001) 479-485
31. Wagner G.C., Tekirian T.L., and Cheo C.T. Sexual differences in sensitivity to methamphetamine toxicity. J. Neural Transm. Gen. Sect. 93 (1993) 67-70
32. Xie T., McCann U.D., Kim S., Yuan J., and Ricaurte G.A. Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity. J. Neurosci. 20 (2000) 7838-7845
33. Yan Q.-S. Ethanol-induced, nonexocytotic [3H]dopamine release from rat striatal nucleus accumbens slices. Alcohol 27 (2002) 127-134
34. Yu L., and Liao P.-C. Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice. J. Neural Transm. 107 (2000) 419-427
35. Yu L., and Wagner G.C. Influence of gonadal hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity. J. Neural Transm. (P-D Sect.) 8 (1994) 215-221